Detalhe da pesquisa
1.
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer.
Breast Cancer Res
; 26(1): 30, 2024 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378689